Essayer OR - Gratuit
Saving Lives with BSL-4 Labs
Bio Spectrum
|February 2026
Starting a new era of India's health security, a biosafety level 4 (BSL-4) lab is being built at the cost of Rs 362 crore at Gujarat Biotechnology Research Centre in Gandhinagar. Although this will be India's second high-level lab after the National Institute of Virology in Pune (established in 2012), this is the first lab being built by a state government, with an area of 11,000 square metres. Back in 2024, the Defence Research and Development Organisation (DRDO) took a significant step in enhancing India's chemical-biological defence capabilities with the inauguration of a BSL-4 laboratory at the Defence Research and Development Establishment (DRDE) in Gwalior.
India has been lagging behind for many years due to the cutting-edge research being done in the world, but the establishment of such BSL-4 bio-containment facilities in the country can provide new opportunities to the youth working in the biotechnology sector and help India emerge as a global leader in years to come.
According to reports, with 3,000 square metres of lab space, the Wuhan Institute of Virology in China is one the largest BSL-4 lab in the world, later overtaken by the National Bio and Agro-Defense Facility at Kansas State University in the US which boasts over 50,000 square metres of lab space including BSL-3 and BSL-4 facilities.
The global distribution of BSL-4 laboratories has evolved significantly over the past few decades, reflecting the growing recognition of the need for high-containment facilities in various regions. While historically concentrated in North America and Europe, there has been a notable increase in BSL-4 labs across Asia, Africa, and Australia in recent years.
Cette histoire est tirée de l'édition February 2026 de Bio Spectrum.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE Bio Spectrum
Bio Spectrum
Park Medi World buys KP Institute of Medical Sciences for Rs 245 Cr
Park Medi World Limited, North India's second largest chain of hospitals, has agreed to acquire KP Institute of Medical Sciences (KPIMS), in an all-cash transaction amounting to Rs 245 crore.
1 min
February 2026
Bio Spectrum
Biofabri and Bharat Biotech ink technology transfer agreement to advance global access to MTBVAC
Biofabri, a global human vaccine development company that is part of Spain-based Zendal group, and Bharat Biotech International Limited (BBIL) in Hyderabad, a global leader in vaccine innovation and manufacturing, have announced the signing of a Technology Transfer Agreement.
1 min
February 2026
Bio Spectrum
PM launches Ayush Mark, setting global quality benchmarks for India's traditional medicine
In a historic and visionary move that marks a defining moment for India's traditional medicine ecosystem, Prime Minister (PM) Narendra Modi has launched the Ayush Mark, establishing a globally aligned quality certification framework for Ayush products and services.
1 min
February 2026
Bio Spectrum
Novo Nordisk launches world's most prescribed GLP-1 drug Ozempic in India
Novo Nordisk, a global healthcare company, has announced the launch of Ozempic (injectable semaglutide) in India.
1 min
February 2026
Bio Spectrum
Symbiotec Pharmalab files DRHP with SEBI for IPO aggregating upto Rs 2180 Cr
Indore-based Symbiotec Pharmalab, a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms-organic chemistry, biotechnology and complex injectables, has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI).
1 min
February 2026
Bio Spectrum
Centre announces special dispensation to deep-tech startups in DSIR accreditation process
Union Minister of State (Independent Charge) for Science and Technology Dr Jitendra Singh has announced a major relaxation in the mandatory three-year survival condition for deep-tech startups to get recognition under the Industrial R&D Promotion Programme of Department of Scientific and Industrial Research (DSIR).
1 min
February 2026
Bio Spectrum
Kashiv BioSciences secures Rs 648 Cr financing from UBI
Kashiv BioSciences, a biopharmaceutical company, has secured financing of Rs 648 crore from the Union Bank of India.
1 min
February 2026
Bio Spectrum
S&T Minister inaugurates Biotechnology Research and Innovation Council (BRIC) Secretariat
The Union Minister of (Independent State Charge) for Science and Technology (S&T) Dr Jitendra Singh recently inaugurated the Biotechnology Research and Innovation Council (BRIC) Secretariat by unveiling the inaugural curtain, marking the official opening of a new milestone in India's biotechnology journey.
1 min
February 2026
Bio Spectrum
Senores Pharmaceuticals makes Rs 91 Cr acquisition of Apnar Pharma
Senores Pharmaceuticals has entered into a definitive agreement to acquire 100 per cent equity stake in Apnar Pharma, along with the acquisition of five Abbreviated New Drug Applications (ANDAs), marking a significant milestone in Senores' growth strategy across regulated pharmaceutical markets.
1 min
February 2026
Bio Spectrum
Intas Pharmaceuticals collaborates with IntegriMedical
Ahmedabad-based Intas Pharmaceuticals has entered into an exclusive agreement with IntegriMedical, the technology leader behind India's first NeedleFree Injection System (N-FIS), to introduce this revolutionary technology for use in IVF and gynaecology treatments across India. This marks a significant milestone in IVF and women's health.
1 min
February 2026
Listen
Translate
Change font size
